Clincosm LogoSign in Get a demo

glucagonoma

Showing 1 - 7 of 7
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

DOTATOC PET/CT for Imaging NET Patients

Recruiting
  • Neuroendocrine Tumors
  • +15 more
  • 68Ga-DOTATOC PET/CT
  • 18F-FDG PET/CT
  • Vancouver, British Columbia, Canada
    BC Cancer
Nov 2, 2022

Gastrinoma, Glucagonoma, Insulinoma Trial in United States (temozolomide, capecitabine, laboratory biomarker analysis)

Active, not recruiting
Has Results
  • Gastrinoma
  • +6 more
  • Anaheim, California
  • +322 more
Oct 14, 2022

Gastrinoma, Glucagonoma, Insulinoma Trial in United States (regorafenib, laboratory biomarker analysis)

Completed
Has Results
  • Gastrinoma
  • +8 more
  • Scottsdale, Arizona
  • +4 more
Nov 15, 2021

Gastrinoma, Glucagonoma, Insulinoma Trial in Stanford (Capecitabine, Temozolomide, Bevacizumab)

Completed
Has Results
  • Gastrinoma
  • +8 more
  • Stanford, California
    Stanford University Medical Center
Apr 8, 2021

Gastrinoma, Glucagonoma, Insulinoma Trial in Boston (everolimus, )

Terminated
Has Results
  • Gastrinoma
  • +6 more
  • Boston, Massachusetts
    Ecog-Acrin
Dec 1, 2020

Gastrinoma, Glucagonoma, Insulinoma Trial (dovitinib lactate, pharmacological study, laboratory biomarker analysis)

Withdrawn
  • Gastrinoma
  • +5 more
  • dovitinib lactate
  • +2 more
  • (no location specified)
Jul 18, 2017

Advanced Adult Primary Liver Cancer, Anaplastic Thyroid Cancer, Bone Metastases Trial in Columbus (recombinant interleukin-12,

Completed
  • Advanced Adult Primary Liver Cancer
  • +126 more
  • recombinant interleukin-12
  • ABI-007/carboplatin/trastuzumab
  • Columbus, Ohio
    Ohio State University Medical Center
Feb 27, 2013